Drug: |
Belzutifan |
|||
---|---|---|---|---|
Trial: |
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
University of Michigan1500 East Medical Center Dr |
Principal Investigator: |
|
---|---|
Contact: |
Study Coordinator 734-647-8902 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Michigan Website: |
https://www.umms.med.umich.edu/engage/disp_pub_main.do |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.